Redhill Biopharma Ltd
NASDAQ:RDHL
Redhill Biopharma Ltd
NASDAQ:RDHL
Price:
0.451 USD
4.57%
Market Closed
Updated:
May 2, 2024
Section:
Relative Value
The Relative Value of one
RDHL
stock under the Base Case scenario is
0.654
USD.
Compared to the current market price of 0.451 USD,
Redhill Biopharma Ltd
is
Undervalued by 31%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RDHL
Relative Value
Base Case
0.654
USD
Undervaluation 31%
Valuation Multiples
Multiples Across Competitors
RDHL Competitors Multiples
Redhill Biopharma Ltd Competitors
Redhill Biopharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
13.4m USD | 2.1 | 0.6 | 0.5 | 0.7 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 | -5 347 888.9 | -5 459 134.4 | -5 046 864.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
736B USD | 21.6 | 140.7 | 63.4 | 72.8 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
4T DKK | 17.1 | 47.6 | 34.8 | 37.9 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 | -15 783.5 | 3 846.3 | 17 702.3 | |
| JP |
|
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
|
82T JPY | 255.8 | 9 733.7 | 1 771.8 | 4 320.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
363B USD | 4.4 | 9 | 11.9 | 15.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
326.6B USD | 5.4 | 894.7 | 44.5 | 86.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
188.7B GBP | 5.1 | 39.6 | 140.8 | 225.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
182B CHF | 4.3 | 13.4 | 9.8 | 16.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
175.9B CHF | 3 | 15.3 | 8.7 | 10.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
